# Seers Technology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/seers-technology-co

- Industry: Healthcare IT
- Headquarters: Pyeongtaek, South Korea
- Website: www.seerstech.com
- Total disclosed funding: $19M
- Latest round: Series C (Dec 1, 2021)
- Investors on record: 8

## About

Founded in 2009, and based in Pyeongtaek, South Korea, Seers Technology Co., LTD. operates as a company that provides remote patient monitoring solutions for telehealth/telemedicine services and cardiac monitoring solutions for patients.

The company was established in 2009, with the capital of SKW 300 million. Through out 2010 to 2018, the company acquired seven critical certificates in medical sector, including ISO13485 certification, ISO 9001/14001 certification, US FDA and Special 510K certification for telemedicine terminal. in 2020, the company reached partnership with Seoul National University Hospital, for its mobiCARE-MC100 clinical research. It also work with Hallym University Sacred Heart Hospital to commercialise medical researches.

The company produces and develops wearable biosensors, patient monitoring system, medical AI, and medical advanced materials. The company's product has been adopted by over 400 hospitals domestically, commercialised inpatient monitoring system and applied into the global telemedicine market. Its product mobiCARE-MC100 has been in sales contract with Daewoong Pharmaceutical, a public company in South Korea.

## Funding rounds

- Series C, Dec 1, 2021, $15M — Kyobo Life Insurance, Korea Investment & Securities, Lifecore Partners, Daewoong Pharmaceutical, Friend Investment Partners
- Series B, Dec 1, 2020 — Heungkuk Securities, Winvest Venture Capital, Lifecore Partners, Friend Investment Partners
- Series A, Mar 1, 2020 — Tigris Investment
- Seed, Jun 1, 2019, $3.4M — Winvest Venture Capital

## Investors

- Winvest Venture Capital (https://capitalatlas.ai/funds/winvest-venture-capital) — Seed, Series B
- Tigris Investment (https://capitalatlas.ai/funds/tigris-investment) — Series A
- Heungkuk Securities — Series B
- Lifecore Partners — Series B, Series C
- Friend Investment Partners (https://capitalatlas.ai/funds/friend-investment-partners) — Series B, Series C
- Kyobo Life Insurance — Series C
- Korea Investment & Securities (https://capitalatlas.ai/funds/korea-investment-securities) — Series C
- Daewoong Pharmaceutical — Series C